Open AccessAzadirachtin-A a bioactive compound from Azadiracta indica is a potential inhibitor of SARS-CoV-2 main protease
Author(s) -
Eustace Bonghan Berinyuy,
Jonathan Ibrahim,
Uchenna Blessing Alozieuwa
Publication year - 2021
Language(s) - English
DOI - 10.53858/arocpb01010108
Subject(s) - docking (animal) , protease , chemistry , in silico , covid-19 , pharmacology , protease inhibitor (pharmacology) , enzyme , active site , biochemistry , stereochemistry , virology , biology , virus , medicine , infectious disease (medical specialty) , veterinary medicine , disease , viral load , gene , pathology , antiretroviral therapy